Gagliano et al. demonstrated that cabergoline reduces cell viability in non-functioning pituitary adenomas by inhibiting VEGF secretion, of which the modulation might mediate the effects of DA agonists on cell proliferation in non-functioning adenoma [[29]]. The gene discussed is VEGFA; the disease is adenoma.